Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better. From the week of November 17th, we plan to work on 22 projects. Review the complete list of planned activities in this post.

On October 24, 2025, the BfArM (Federal Institute for Drugs and Medical Devices) published the final version of the 2026 OPS procedure coding classification. The OPS, together with the ICD-10-GM (International Statistical Classification of Diseases and Related Health Problems, 10th revision, German Modification), forms the basis for the reimbursement systems in outpatient and inpatient care in Germany. Multiple new procedure codes were introduced in several fields, including cardiovascular, endoscopy, peripheral vascular, and orthopedics.

On November 4, 2025, NHS England published an updated work plan for the development of Clinical Commissioning Policies for specialised services. One new MedTech-related policy concerning cochlear implantation in single-sided deafness was added to the work program, and none have been published since the previous update. The status of ongoing policies has also been updated.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Sustainability Publications Digest. In a recent publication, Parker et al. explored how Canada’s Drug Agency and England’s NICE have started to incorporate environmental sustainability into health technology assessments.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Seddik et al. conducted a systematic review to map how the societal impact of healthcare interventions has been measured globally.

On October 27, 2025, the annual update of the Swedish procedure coding system (KVÅ) was released to come into force on January 1, 2026. A total of 35 new surgical (KKÅ) procedure codes were added in the fields of nephrology and urology, obstetrics and gynecology, interventional radiology, men’s health, and radiotherapy. Furthermore, 90 new medical (KMÅ) procedure codes were introduced concerning diagnostic imaging, radiology, gastrointestinal, and other fields.

In October 2025, the Dutch Healthcare Institute (ZIN) published the plan for implementing the program, “Reimbursement within Research,” which allows temporary reimbursement under basic health insurance during the research period for existing medical specialist care and medical devices with limited evidence of effectiveness. The Minister of Health, Welfare, and Sport will consider the ZIN implementation plan and decide whether to initiate the program. If the decision is positive, the program's launch is expected in the fourth quarter of 2025.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, Sciattella et al. shared the outcomes of the 2024 Italian Health Policy Forum, which explored how Italy is preparing for the implementation of the EU HTA Regulation 2021/2282.

On October 21, 2025, the French National Authority for Health (HAS) issued positive opinions on the inclusion of targeted next-generation sequencing-based panels for patients with multiple myeloma and lung cancer in the NABM Nomenclature for regular reimbursement. Currently, these tests are temporarily reimbursed within the innovative payment scheme (RIHN). These HAS assessments are performed as a part of the RIHN reform and ‘cleaning up’ the List of temporarily covered tests.

On November 5, 2025, the Swiss Federal Council approved a set of adjustments and additions to the new comprehensive outpatient tariff system, which comprises TARDOC and the outpatient flat rates. The implementation of changes before the system's launch on January 1, 2026, was requested by the tariff partners in July 2025. The adjustments primarily affect emergency services, oncology, wound care, and pathology.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Nurchis et al. conducted a comparative analysis of how EU, European Economic Area, and European Free Trade Association countries have institutionalized health technology assessment for medical devices.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better. From the week of November 03rd, we plan to work on 21 projects. Review the complete list of planned activities in this post.